India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says

Reuters · Published 2h ago · Impact 80%

Steady / neutral54%

PositivePossible support for stability, investment or market confidence

RiskInflation, volatility, borrowing costs or weaker growth

Read the full story at Reuters →

More in Finance

The transpacific yen team has a weak link in Ueda
CNBC Daily Open: A U.S. yen intervention dressed in euros
Toyota unveils ¥1 trillion share buyback and raises profit outlook
New stock market closing auction triggers confusion

GlobeVerge Signal: A transparent, keyword-based read on this story's tone and stakes—not financial, political or safety advice. The summary above is the original publisher's excerpt, not AI-generated or rewritten by GlobeVerge. Open the original source link before acting on any story.

About Editorial Policy Sources Contact